New Report by Modern Caregiving Solutions Reveals Critical Insights on...
The top stocks and shares Isa offers ahead of the deadline next week
Shah Plastic Surgery Expands with New Premises and Procedures
Holiday Inn Express near Worthington, Reynoldsburg Quality Inn change hands
Sustainable Canadian Agricultural Partnership launches April 1, 2023
The top stocks and shares Isa offers ahead of the deadline next week
Shah Plastic Surgery Expands with New Premises and Procedures
Holiday Inn Express near Worthington, Reynoldsburg Quality Inn change hands
Sustainable Canadian Agricultural Partnership launches April 1, 2023
Pembrolizumab
Business / FinanceBy Business Wire2023-03-31 12:07:00
Recommendation for approval based on Phase 3 TRANSFORM study, supporting the potential of Breyanzi in earlier lines of therapy in this patient population...
Business / FinanceBy Rtt News2023-03-31 12:40:27
(RTTNews) - Fennec Pharmaceuticals Inc. (FENC) announced on Friday that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines...
HealthPress Release2023-03-31 10:30:00
Strategic reprioritization of the Company's pipeline to focus on key clinical assets and overall streamlining of corporate structure and workforce, resulting...
SciencePress Release2023-03-31 11:00:00
IND application cleared within 6 months of in-licensing CABA-201 binder CABA-201 data package and experience from prior autoimmune cell therapy INDs informed...
SciencePress Release2023-03-31 12:00:00
Media Release Efti plus pembrolizumab achieved mOS of 9.9 months and a 39% OS rate at 21 months, which compare favourably to typical 6-9 months mOS and a...
SciencePress Release2023-03-31 12:03:00
~ First Therapy Recommended for Approval in the European Union for Reducing the Risk of Cisplatin-induced Hearing Loss (Ototoxicity) in Pediatric Patients...
HealthBy Https://Www Facebook Com/Bbcnews2023-03-29 00:26:05
A life-extending drug for advanced cervical cancer will be made available to NHS patients in England, like it is in Scotland, new recommendations say....
Business / FinanceBy Business Wire2023-03-27 06:00:00
Incyte INCY today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Pemazyre (pemigatinib), a selective fibroblast...
HealthPress Release2023-03-30 11:20:40
Systematic Lupus Erythematosus Drug market 2023 This report is the culmination of a study that utilized different methodologies such as PESTEL, PORTER and...
HealthPress Release2023-03-31 21:19:00
New formulation allows twice-daily dosing in patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is...
Business / FinanceBy Business Wire2023-03-30 12:28:00
Citryll, a clinical-stage biotech company developing first-in-class therapeutics to treat autoimmune and autoinflammatory diseases, today announced that Dr....
Business / FinanceBy Business Wire2023-03-27 21:15:00
KEYTRUDA plus chemotherapy reduced risk of disease progression or death by 46% in patients whose cancer was mismatch repair proficient (pMMR) and by 70% in...
Business / FinanceBy Fintel2023-03-31 08:59:07
Commercial-stage biopharma stock Y-mAbs Therapeutics Inc ( US:YMAB ), reported fourth quarter and full year 2022 results on Thursday post market, sending...
SciencePress Release2023-03-31 11:30:00
NEW YORK, March 31, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc.(NASDAQ: TGTX),today announced that the Committee for Medicinal Productsfor Human Use...
SciencePress Release2023-03-31 10:00:00
Results from three participants demonstrated no incidence of acute rejection at durations of 56, 154, and 232 days Strong graft function observed in all...
HealthPress Release2023-03-31 02:00:00
SHANGHAI, March 31, 2023 /PRNewswire/ -- Ablaze Pharmaceuticals, a biotech company that is focused on developing Targeted Radiotherapy (TRT) to benefit...
HealthPress Release2023-03-31 12:00:00
Reflecting Organization's Focus on Rare Kidney Disease KING OF PRUSSIA, Pa., March 31, 2023 /PRNewswire/ -- NephCure, formerly NephCure Kidney International,...
Business / FinancePress Release2023-03-31 06:16:00
STOCKHOLM, March 31, 2023 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today the publication of additional...
Business / FinanceBy Business Wire2023-03-31 06:00:00
H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G ApoE4 and Lumipulse G Pan-ApoE assays...
HealthPress Release2023-03-31 10:25:00
STOCKHOLM, March 31, 2023 /PRNewswire/ -- The shareholders of Medivir AB (publ), reg. no. 556238-4361, with its registered office in Huddinge, Stockholm, are...